Compare ARAI & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARAI | ZTEK |
|---|---|---|
| Founded | 2020 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.3M | 78.2M |
| IPO Year | N/A | N/A |
| Metric | ARAI | ZTEK |
|---|---|---|
| Price | $2.26 | $0.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 98.9K |
| Earning Date | 11-14-2025 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $98,175.00 | ★ $657,134.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $900.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2225.73 |
| 52 Week Low | $2.33 | $0.62 |
| 52 Week High | $40.00 | $1.84 |
| Indicator | ARAI | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 33.82 | 48.49 |
| Support Level | $2.33 | $0.80 |
| Resistance Level | $3.35 | $0.89 |
| Average True Range (ATR) | 0.28 | 0.09 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 24.31 | 15.42 |
Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advanced chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.